- Report
- July 2025
- 194 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 188 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 183 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 472 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 486 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- April 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- July 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- July 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4001EUR$4,490USD£3,471GBP
- Report
- July 2025
- 377 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 198 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 173 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 250 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 494 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 179 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 224 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 163 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 282 Pages
Global
From €5213EUR$5,850USD£4,522GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more